li auto inc's third-quarter delivery volume increased by over 40% year-on-year, cspc pharma's net profit in the first nine months was about 4.5 billion yuan| Selected announcement of Hong Kong stocks on October 31.

① Ideal Auto's delivery volume in the third quarter increased by more than 40% year-on-year. How was the performance? ② The net profit of CSPC Group in the first 9 months was about 4.5 billion yuan. How fast is the growth rate?

cls.cnOct 31 09:40 ET

cspc pharma (01093.HK) issued a profit warning: expected profit for the first three quarters to decrease by about 16%.

CSPC Pharma (01093.HK) announced on October 29th that the company expects its attributable net profit for the nine months ending September 30, 2024 to decrease by approximately 16% compared to the same period last year, to about RMB 4,494,641,000. The decrease in net profit is mainly due to a 3% decrease in revenue from the pharmaceutical business compared to the same period last year. The main reasons are as follows: (i) In the field of anti-tumor treatment, the prices of two products, jing-jin-ji's Tianyouli and Domeison, were reduced by about 58% and 23% respectively in the centralized procurement of pharmaceuticals in the "3+N" alliance. With the joint procurement of the alliance in March of this year.

Gelonghui FinanceOct 31 05:58 ET

Express News | CSPC Pharmaceutical - Expected Result Due to Decrease in Revenue of Finished Drugs Business

ReutersOct 31 05:54 ET

Express News | CSPC Pharmaceutical Sees Decrease in Profit Attributable of 16% for Nine Months

ReutersOct 31 05:54 ET

CSPC PHARMA: PROFIT WARNING

HKEXOct 31 05:53 ET · Announcements

zheshang: Continuous realization of technological innovation upgrade driving the continuous improvement of performance expectations for innovative drugs and industry chain.

The commercialization period of innovative drugs in the industry chain, driven purely by incremental value, is entering the phase of realization. The scarce incremental prosperity of the pharmaceutical sector continues to rise, with increasing international competitiveness, and there is still room for upward valuation.

Zhitong FinanceOct 29 22:28 ET